Pyrotech
Latest round
- Series A
Last raised
- May 2024
Total raised
- $97M
Investors
- 14
About Pyrotech
, trading as Pyrotech, is a pharmaceutical R&D and manufacturing company that primarily provides services such as drug production and wholesale, R&D of biopharmaceutical technologies and products, technical services, technology transfer, and technical consulting. It has R&D centers in Beijing and Shanghai and BD and clinical centers in the US. The co-founder and CEO of the company, Tianjing Deng, graduated from Marquette University and has founded BioDuro. The company focuses on cellular scorching in the field of disease treatment, including inflammatory diseases and tumors. It develops three technology platforms, which are small molecule immunomodulatory new drug research and development platform, biological regulation pyroptosis technology platform, and disease translation research platform. Pyrotech's R&D product pipeline includes three modes of agonists, gene regulation, and inhibitors. The treatment directions of the product pipeline include tumor immunity, hereditary disease, sepsis, kidney damage, asthma, etc. The company generates revenue by providing self-developed technology platforms to develop small molecule drugs in the fields of inflammation and oncology, as well as other disease areas.
Who invested in Pyrotech
14 investors across 3 rounds
See all investors in Pyrotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pyrotech
Who invested in Pyrotech?
Pyrotech has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pyrotech raised?
Pyrotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Pyrotech last raise money?
Pyrotech's most recent round on record is a Series A, in May 2024.
What does Pyrotech do?
, trading as Pyrotech, is a pharmaceutical R&D and manufacturing company that primarily provides services such as drug production and wholesale, R&D of biopharmaceutical technologies and products, technical services, technology transfer, and technical consulting.
Where is Pyrotech headquartered?
Pyrotech is headquartered in Beijing, China.
Which VCs invest in companies like Pyrotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Pyrotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Pyrotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.